Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of capsular opacification with adjunctive mitomycin C in combined glaucoma and cataract surgery

D H Shin1, Y Y Kim, J Ren

  • 1Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI 48201-1423, USA.

Ophthalmology
|July 15, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micro-viscosity of liquid oil confined in colloidal fat crystal networks.

Soft matter·2014
Same author

RIP kinase 3 in necroptosis: does it take two or more to kill?

Cell death and differentiation·2014
Same author

A pilot study of brief heart rate variability biofeedback to reduce craving in young adult men receiving inpatient treatment for substance use disorders.

Applied psychophysiology and biofeedback·2014
Same author

Design and initial characterization of a compact, ultra high vacuum compatible, low frequency, tilt accelerometer.

The Review of scientific instruments·2014
Same author

Examining the mechanism of action of a new device using oral pressure therapy for the treatment of obstructive sleep apnea.

Sleep·2014
Same author

Effects of Dietary Scutellaria baicalensis Extract on Growth, Feed Utilization and Challenge Test of Olive Flounder (Paralichthys olivaceus).

Asian-Australasian journal of animal sciences·2014

Intraoperative mitomycin C (MMC) during glaucoma and cataract surgery significantly reduced posterior capsular opacification (PCO) requiring YAG capsulotomy. Three minutes of MMC application was most effective in preventing PCO after combined surgery.

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Cataract Surgery
  • Ocular Inflammation and Wound Healing

Background:

  • Posterior capsular opacification (PCO) is a common complication after cataract surgery, potentially requiring YAG laser capsulotomy.
  • Primary open-angle glaucoma (POAG) management often involves surgical intervention, with combined procedures offering efficiency but carrying risks of complications like PCO.
  • Mitomycin C (MMC) is an antifibrotic agent used in glaucoma surgery, but its effect on PCO after combined procedures is of interest.

Purpose of the Study:

  • To investigate the incidence of capsular opacification requiring YAG capsulotomy after primary trabeculectomy combined with phacoemulsification and intraocular lens implantation.
  • To evaluate the efficacy of adjunctive subconjunctival mitomycin C (MMC) in preventing posterior capsular opacification (PCO) in patients undergoing primary glaucoma triple procedures (PGTP).

Related Experiment Videos

  • To compare different durations of MMC application (1, 3, and 5 minutes) for their impact on PCO incidence.

    • Main Methods:

    • A prospective randomized study involving 174 patients with POAG undergoing PGTP.
    • Patients were randomized into a control group (no MMC) or an MMC group receiving adjunctive subconjunctival MMC.
    • Kaplan-Meier analysis and Cox proportional hazard regression were used to compare PCO rates and identify influencing factors.

    Main Results:

    • The incidence of PCO requiring YAG capsulotomy was significantly lower in the MMC group compared to the control group (P = 0.004).
    • Three minutes of MMC application demonstrated the most significant reduction in PCO compared to the control group (P = 0.002).
    • Older age and the presence of diabetes mellitus were identified as factors associated with a decreased incidence of YAG capsulotomy for PCO.

    Conclusions:

    • Intraoperative subconjunctival MMC application during combined glaucoma and cataract surgery effectively inhibits PCO in POAG patients.
    • A 3-minute application of 0.5 mg/ml MMC appears sufficient to achieve a long-term decrease in PCO by inhibiting lens epithelial cell proliferation.
    • Adjunctive MMC in PGTP offers a beneficial strategy to reduce the need for subsequent YAG laser treatment for PCO.